Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: A systematic review with meta-analysis of randomized, controlled trials

Journal of the American College of Cardiology

Volumn 62, Issue 23, 2013, Pages 2167-2175

  Sadat, Umar ^a   Usman, Ammara ^b   Gillard, Jonathan H ^c   Boyle, Jonathan R ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b Cavalry Hospital   (Pakistan)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

acute kidney injury; angiography; ascorbic acid; contrast induced nephropathy

Indexed keywords

ASCORBIC ACID; CONTRAST MEDIUM; PLACEBO; SODIUM CHLORIDE;

ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; DRUG EFFICACY; EVENING DOSAGE; HUMAN; INCIDENCE; META ANALYSIS; MORNING DOSAGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL PROTECTION; RISK REDUCTION; SYSTEMATIC ERROR; SYSTEMATIC REVIEW;

EID: 84889867648     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.07.065     Document Type: Article

References (37)

1. B. Frei, L. England, and B.N. Ames Ascorbate is an outstanding antioxidant in human blood plasma Proc Natl Acad Sci U S A 86 1989 6377 6381
2. A. Carr, and B. Frei Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 13 1999 1007 1024
3. S.N. Heyman, S. Rosen, M. Khamaisi, J.M. Idee, and C. Rosenberger Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy Invest Radiol 45 2010 188 195
4. M.A. Albabtain, A. Almasood, H. Alshurafah, H. Alamri, and H. Tamim Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-induced nephropathy: a prospective randomized study J Interv Cardiol 26 2013 90 96
5. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Available at: http://handbook.cochrane.org/. Accessed September 16, 2013.
6. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
7. M. Borenstein, L.V. Hedges, J.P.T. Higgins, and H.R. Rothstein Publication bias. Introduction to meta-analysis 2009 West Sussex, United Kingdom: John Wiley & Sons, Ltd. 277 292
8. A. Momeni, A. Ebrahimi, and A. Khaledi Comparison of three methods of contrast nephropathy prophylaxis in azotemic patients Iranian J Kidney Dis 2011 5 10
9. K. Spargias, E. Alexopoulos, and S. Kyrzopoulos Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention Circulation 110 2004 2837 2842
10. A. Boscheri, C. Weinbrenner, B. Botzek, K. Reynen, E. Kuhlisch, and R.H. Strasser Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction Clin Nephrol 68 2007 279 286
11. S.H. Jo, B.K. Koo, and J.S. Park N-acetylcysteine versus AScorbic acid for Preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial Am Heart J 157 2009 576 583
12. L. Zhou, and H. Chen Prevention of contrast-induced nephropathy with ascorbic acid Intern Med 51 2011 531 535
13. K. Komiyama, T. Tejima, Y. Tanab, and H. Sakurada Is ascorbic acid effective in preventing contrast-induced acute kidney injury? Am J Cardiol 105 2011 29A
14. M. Brueck, H. Cengiz, and R. Hoeltgen Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single center, prospective, double-blind, placebo-controlled trial J Invasive Cardiol 25 2013 276 283
15. R. Li, and H. Chen Prevention of contrast-induced nephropathy with ascorbic acid Heart 98 Suppl 2 2012 E211
16. S. Hamdi, W. Selmi, A. Hraiech, W. Jomaa, K.B. Hamda, and F. Maatouk Prevention of contrast induced nephropathy in patients undergoing coronarography with ascorbic acid J Am Coll Cardiol Intv 6 Suppl S 2013 S22
17. S.H. Jo, B.K. Koo, and J.S. Park N-acetylcysteine versus ascorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial Am Heart J 157 2009 576 583
18. G.H. Guyatt, A.D. Oxman, R. Kunz, G.E. Vist, Y. Falck-Ytter, and H.J. Schunemann What is "quality of evidence" and why is it important to clinicians? BMJ 336 2008 995 998
19. S.J. Padayatty, H. Sun, and Y. Wang Vitamin C pharmacokinetics: implications for oral and intravenous use Ann Intern Med 140 2004 533 537
20. G. Barja Ascorbic acid and aging H.J. Robin, Ascorbic Acid: Biochemistry and Biomedical Cell Biology 1996 Plenum New York, NY 157 188
21. M. Valko, H. Morris, and M.T. Cronin Metals, toxicity and oxidative stress Curr Med Chem 12 2005 1161 1208
22. M. Kruszewski Labile iron pool: the main determinant of cellular response to oxidative stress Mutat Res 531 2003 81 92
23. J. Suh, B.Z. Zhu, and B. Frei Ascorbate does not act as a pro-oxidant towards lipids and proteins in human plasma exposed to redox-active transition metal ions and hydrogen peroxide Free Radic Biol Med 34 2003 1306 1314
24. B.H. Bielski, H.W. Richter, and P.C. Chan Some properties of the ascorbate free radical Ann N Y Acad Sci 258 1975 231 237
25. N. Gokce, J.F. Keaney Jr., and B. Frei Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease Circulation 99 1999 3234 3240
26. T. Motoyama, H. Kawano, and K. Kugiyama Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: effect of vitamin C Am J Physiol 273 1997 H1644 H1650
27. P. Sridulyakul, N. Wongeak-In, and S. Patumraj Correlations between endothelial functions and ROS detection in diabetic microvascular wall: early and late ascorbic acid supplementation Int J Vasc Med 2012 2012 709695
28. S.J. Duffy, N. Gokce, and M. Holbrook Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension Am J Physiol Heart Circ Physiol 280 2001 H528 H534
29. S.K. Hetey, M.L. Kleinberg, W.D. Parker, and E.W. Johnson Effect of ascorbic acid on urine pH in patients with injured spinal cords Am J Hosp Pharm 37 1980 235 237
30. C.H. Barton, M.L. Sterling, R. Thomas, N.D. Vaziri, C. Byrne, and G. Ryan Ineffectiveness of intravenous ascorbic acid as an acidifying agent in man Arch Intern Med 141 1981 211 212
31. C. Bannwart, V. Hagmaier, E. Straumann, H. Hofer, J.P. Vuillemier, and G. Rutishauser [Modification of urinary pH through ascorbic acid] Helv Chir Acta 48 1981 425 428
32. R.J. Alpern Renal Acidification Mechanisms 6th edition 2000 WB Saunders Philadelphia, PA
33. B. Halliwell, and J.M. Gutteridge Role of free radicals and catalytic metal ions in human disease: an overview Methods Enzymol 186 1990 1 85
34. G. Cohen The Fenton reaction 1985 CRC Press Boca Raton, FL
35. H.E. Sauberlich Bioavailability of vitamins Prog Food Nutr Sci 9 1985 1 33
36. J. Blanchard, T.N. Tozer, and M. Rowland Pharmacokinetic perspectives on megadoses of ascorbic acid Am J Clin Nutr 66 1997 1165 1171
37. J. Lykkesfeldt, S. Christen, L.M. Wallock, H.H. Chang, R.A. Jacob, and B.N. Ames Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes Am J Clin Nutr 71 2000 530 536